A Covid-19 patient who was administered with DRDO’s 2-DG drug dies in JMCH

Guwahati, (NKTV): In a recent Development, a Covid-19 patient, who was administered the new 2-DG (2-Deoxy-D-Glucose), died on Sunday night due to post-Covid-19 complications. The patient, a young male, was undergoing treatment at the Jorhat Medical College Hospital (JMCH) for Covid-19. He was the first person in the state to be administered with the new drug.

The anti-Covid-19 drug is developed by the defence research and development organisation (DRDO) in collaboration with Dr Reddy’s Laboratories. The drug comes in powder form in a sachet, which is taken orally by dissolving it in water. The patient reportedly procured the drug from his uncle who works at the DRDO in Hyderabad as a senior scientist.

He later dispatched it JMCH and requested to be administered. According to superintendent of JMCH Dr. Purnima Baruah, the patient had been administered the drug since May 22 and had tested negative in RT-PCR test after completion of the doses. He was then shifted to the general ICU from Covid-19 ICU but on Sunday night, he died of post-Covid-19 complications, she said. DRDO chairman Dr G Satheesh Reddy said the drug had gone through complete trials across 30 hospitals, on a large number of patients.

392 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

More like this
Related

গুৱাহাটীবাসীয়ে শীঘ্ৰে লাভ কৰিব আৰু এখন অত্যাধুনিক উদ্যান

ব্ৰহ্মপুত্ৰৰ পাৰৰ সৌন্দৰ্যবৰ্ধনক নতুন মাত্ৰা দিব উদ্যানখনে। বৃহস্পতিবাৰে নিৰ্মিয়মান...

তামাৰহাটৰ গঙ্গাধৰ নৈত এতিয়া অবৈধ বালি খনন

ডাম্পাৰ আৰু নচলিববাঁহ বান্ধি দিলে ৰাইজেউত্তাল তামাৰহাট তামাৰহাটৰ গঙ্গাধৰ নৈত...

জম্মু-কাশ্মীৰ, হিমাচল, উত্তৰাখণ্ডত তাপমান নামিছে শূন্য ডিগ্ৰীৰ তললৈ

উৎকট শীত প্ৰবাহে গ্রাস কৰিছে সমগ্র উত্তৰ ভাৰতজম্মু-কাশ্মীৰ, হিমাচল,...

হাতীগাঁৱৰ নাহৰণি পথত ছুৰিকাঘাতৰ শিহৰণকাৰী ঘটনা

তেজৰ টোপাল লাগি থকা জোতা-হেলমেট ৰাস্তাতGMCHত মৃত্যু হ’ল মৰাণৰ...